Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy features.

[1]  J. Fütterer,et al.  Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies? , 2018, World Journal of Urology.

[2]  F. Montorsi,et al.  Impact of multiparametric MRI and MRI-targeted biopsy on pre-therapeutic risk assessment in prostate cancer patients candidate for radical prostatectomy , 2018, World Journal of Urology.

[3]  D. Margolis,et al.  MRI‐Targeted or Standard Biopsy for Prostate‐Cancer Diagnosis , 2018, The New England journal of medicine.

[4]  François Cornud,et al.  Precision Matters in MR Imaging-targeted Prostate Biopsies: Evidence from a Prospective Study of Cognitive and Elastic Fusion Registration Transrectal Biopsies. , 2018, Radiology.

[5]  L. Salomon,et al.  Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy , 2017, World Journal of Urology.

[6]  Adam T Froemming,et al.  The Incremental Role of Magnetic Resonance Imaging for Prostate Cancer Staging before Radical Prostatectomy. , 2017, European urology.

[7]  H. G. van der Poel,et al.  EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. , 2017, European urology.

[8]  J Alfred Witjes,et al.  Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis. , 2016, European urology.

[9]  M. Wirth,et al.  Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound‐fusion biopsy for the diagnosis of prostate cancer , 2015, BJU international.

[10]  R. Saouaf,et al.  Multiparametric MRI Improves Accuracy of Clinical Nomograms for Predicting Extracapsular Extension of Prostate Cancer. , 2015, Urology.

[11]  P. Choyke,et al.  The Role of Magnetic Resonance Image Guided Prostate Biopsy in Stratifying Men for Risk of Extracapsular Extension at Radical Prostatectomy. , 2015, The Journal of urology.

[12]  J. Bernhard,et al.  Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. , 2015, European urology.

[13]  H. G. van der Poel,et al.  Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients. , 2015, Urologic oncology.

[14]  David Y. Lu,et al.  Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology. , 2014, The Journal of urology.

[15]  Y. Yamada,et al.  A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy. , 2013, European urology.

[16]  M. Terris,et al.  Delayed radical prostatectomy for intermediate‐risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH database , 2013, The Prostate.

[17]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[18]  A. Renshaw,et al.  Biochemical Outcome after radical prostatectomy, external beam Radiation Therapy, or interstitial Radiation therapy for clinically localized prostate cancer , 1998 .

[19]  Laurent Lemaitre,et al.  Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. , 2019, The Lancet. Oncology.

[20]  F. Beuvon,et al.  Gleason Score Determination with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Guided Prostate Biopsies--Are We Gaining in Accuracy? , 2016, The Journal of urology.